Valeant Pharmaceuticals International Inc (VRX)

10.75
0.11 1.01
NYSE : Health Care
Prev Close 10.86
Open 10.83
Day Low/High 10.70 / 10.95
52 Wk Low/High 10.35 / 38.50
Volume 8.91M
Avg Volume 18.96M
Exchange NYSE
Shares Outstanding 347.84M
Market Cap 3.73B
EPS -6.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Bill Ackman to Attend Ira Sohn Conference

Bill Ackman to Attend Ira Sohn Conference

Ackman, who skipped last year's conference, will take the stage on May 8.

Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members

Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members

The Street took a look at the top 15 activist hedge funds and their director-election records over the past six years

Democrats Target Trump SEC Pick Clayton Over Conflicts

Democrats Target Trump SEC Pick Clayton Over Conflicts

The Wall Street lawyer told lawmakers on Capitol Hill that he sees "meaningful" room to bolster the current lackluster IPO markets.

Valeant CEO Compensation Revealed, Shares Climb

Valeant CEO Compensation Revealed, Shares Climb

CEO Joseph Papa takes home approximately $62.7 million yearly.

Starboard's Smith Leads Activists in Naming Dissident Directors

Starboard's Smith Leads Activists in Naming Dissident Directors

The Street took a look at the top activist hedge funds and their director-election records over the past six years.

Valeant Closes Down Slightly After Completing Refi

Valeant Closes Down Slightly After Completing Refi

Valeant shares were down nearly 2% at one point on news that it has completed several refinancing transactions.

Regenxbio Leads Biotech Movers Ahead of Market's Open

Regenxbio Leads Biotech Movers Ahead of Market's Open

Also on the move were Global Blood Therapeutics, Valeant and Kite Pharma, among others.

Chipotle, Herbalife, Sears: Doug Kass' Views

Chipotle, Herbalife, Sears: Doug Kass' Views

Doug Kass shares his thoughts on Pershing Square, and talks about Sears.

10 Things We Learned From Our Daily Facebook Show With Jim Cramer

10 Things We Learned From Our Daily Facebook Show With Jim Cramer

TheStreet's Jim Cramer discusses the hottest stocks of the day on our daily Facebook Live show, airing weekdays at 10 a.m. EST.

Why Are So Many Employees Selling Stock Options - And Is That Really a Good Idea?

Why Are So Many Employees Selling Stock Options - And Is That Really a Good Idea?

A new study shows U.S. employees love their employee stocks and stock options, and like to exercise them early and often.

How to Deal With the Trader's Dilemma

How to Deal With the Trader's Dilemma

Managing risk requires accepting that you'll be wrong sometimes and planning accordingly; just ask Bill Ackman.

Closing Bell: Citi Dumps SeaWorld; U.S. Stocks Churn as Health Care Falls

Closing Bell: Citi Dumps SeaWorld; U.S. Stocks Churn as Health Care Falls

Stocks churn around the flatline to end the week as a selloff in health care counters gains seen elsewhere.

Broad Gains Overshadow Health Care Losses to Boost Wall Street

Broad Gains Overshadow Health Care Losses to Boost Wall Street

Stocks rise on Friday even as a selloff in health care extends into its second day.

Stocks Creep Lower as Health Care Selloff Extends Into Day 2

Stocks Creep Lower as Health Care Selloff Extends Into Day 2

Stocks creep lower on Friday as a selloff in health care extends into its second day.

This Key Measure Shows the S&P Could Be Headed for a 5% Pullback

This Key Measure Shows the S&P Could Be Headed for a 5% Pullback

Oil and natural gas prices are on the downswing and one key measure seems to pointing that we could be nearing a pullback in the S&P.

Stock Futures Mixed as Crude Rises, G-20 Summit Kicks Off

Stock Futures Mixed as Crude Rises, G-20 Summit Kicks Off

Stock futures move mostly higher on Friday as crude oil attempts another rebound to close out the week.

Valeant Shares Skyrocket After Hours on ValueAct Buy

Valeant Shares Skyrocket After Hours on ValueAct Buy

The move comes just days after Bill Ackman's Pershing Square exited the stock.

Jim Cramer on Ackman's Valeant Loss: He Will Be Back

Jim Cramer on Ackman's Valeant Loss: He Will Be Back

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is confident hedge fund manager Bill Ackman will rebound from his multi-billion dollar loss in Valeant Pharmaceuticals.

A Quick Update on Our Valeant Pharmaceuticals Trade

We have repurchased the short March 17 puts this morning, while selling a March 17 $12 call, to ensure it will be in the black and keep more upside on the table.

Trader's Daily Notebook: Would Somebody Please Change the Channel?

Trader's Daily Notebook: Would Somebody Please Change the Channel?

Most traders will probably wait for the Fed-related dust to settle.

Apple, Facebook and Tesla: Off the Charts

Apple, Facebook and Tesla: Off the Charts

Carolyn Boroden charts Facebook, Apple and Tesla: Here's how tracking 5- and 13-day exponential moving averages can keep you out of the red.

Nucor: Cramer's Top Takeaways

Nucor: Cramer's Top Takeaways

John Ferriola, CEO of Nucor, tells Jim Cramer that 2017 is shaping up to be better than 2016.

Prologis: Cramer's Top Takeaways

Prologis: Cramer's Top Takeaways

Hamid Moghadam, CEO of Prologis, tells Jim Cramer that if you believe ecommerce will continue to grow, so will his company.

12 Years and Still Finding the Bulls for You: Cramer's 'Mad Money' Recap (Tuesday 3/14/17)

12 Years and Still Finding the Bulls for You: Cramer's 'Mad Money' Recap (Tuesday 3/14/17)

Jim Cramer says it's his job to educate and entertain you, as well as help you make and save money.

Cisco Systems, CyberArk, Check Point Software: 'Mad Money' Lightning Round

Cisco Systems, CyberArk, Check Point Software: 'Mad Money' Lightning Round

Jim Cramer is bullish on Cisco Systems, Check Point Software and CyberArk Software.

Cramer: Is it Time to Buy Valeant?

Cramer: Is it Time to Buy Valeant?

On an inconsistent day in the markets, some ask if now's the time to buy Valeant.

Wild Weather Mutes Activity in a Down Day for Wall Street

Wild Weather Mutes Activity in a Down Day for Wall Street

The weather was wild on Wall Street, but it was a lot quieter indoors where low volume made for a muted day of trading.